Sipponen Pentti, Härkönen Matti, Alanko Arto, Suovaniemi Osmo
Helsinki University Central Hospital, Department of Pathology, Espoo, Finland.
Clin Lab. 2002;48(9-10):505-15.
On the basis of the levels of serum pepsinogen I (S-PGI) and gastrin-17 (S-G-17) as well as Helicobacter pylori - antibodies assayed from a blood sample it is possible to establish with high sensitivity and specificity whether the patient has gastritis, whether the gastritis is atrophic or not and in which part of the stomach the atrophic changes are located. The test enables the identification of patients whose risk of gastric cancer, of the consequences of vitamin B12 deficiency (e.g. elevated levels of homocysteine) or of peptic ulcer is considerably increased and who can then undergo gastroscopy. It also facilitates the diagnosis of non-atrophic Helicobacter gastritis enabling treatment before endoscopy.
根据血液样本中检测的血清胃蛋白酶原I(S-PGI)、胃泌素-17(S-G-17)水平以及幽门螺杆菌抗体,能够以高灵敏度和特异性确定患者是否患有胃炎、胃炎是否为萎缩性以及萎缩性改变位于胃的哪一部分。该检测能够识别出患胃癌风险、维生素B12缺乏后果(如同型半胱氨酸水平升高)或消化性溃疡风险显著增加的患者,这些患者随后可接受胃镜检查。它还有助于非萎缩性幽门螺杆菌胃炎的诊断,从而在内镜检查前进行治疗。